Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'221 0.9%  SPI 13'098 0.7%  Dow 29'684 1.9%  DAX 12'183 0.4%  Euro 0.9498 -0.2%  EStoxx50 3'335 0.2%  Gold 1'660 1.9%  Bitcoin 19'075 0.6%  Dollar 0.9760 -1.6%  Öl 89.2 4.1% 

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
10.08.2022 19:15:41

1 Reason to Sell Novavax Stock, and 1 Reason to Buy

This year hasn't been an easy one for Novavax (NASDAQ: NVAX) investors. After a series of stumbles culminating in its disastrous earnings report on Aug. 8, its shares are down by 60% so far in 2022. And with management slashing its full-year revenue guidance by roughly half, there isn't much hope for smoother sailing for at least a few quarters.For a contrarian investor, that means the stock could be ripe for a buy with the goal of holding it through a turnaround. On the other hand, most of us aren't contrarians, so now could be the time to cut and run, or at least defer a purchase until conditions improve.On that note, here's one argument for selling your shares and one for buying more. Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

INFLATION: WELTWEIT STEIGEN DIE PREISE

Viele Anleger setzen deshalb auf den Aktiv verwalteten Global Inflation Protection Basket. Informieren Sie sich über die breit gestreute Auswahl an robusten Aktien & ETFs.